
Antimicrobial resistance (AMR) is truly a global problem that requires urgent action from policymakers and the health community to avoid preventable deaths. The Absolute Genomics ABx Advantage gene panel is designed to detect major classes of antibiotic resistance. This panel can identify the presence of specific resistance genes that are involved in drug inhibition. The Absolute Genomics ABx Advantage gene panel has 11 antibiotic resistance genes belonging to amino glycoside, β-lactam, fluoroquinolone, macrolide, tetracycline, vancomycin, and multi-drug resistance classifications. The multiplex PCR test takes less than 3 hours to complete. After, the data is used for providing antibiotic resistance stewardship. The OneChoice report powered by Arkstone Medical Solutions for the ABx Advantage gene panel converts PCR data into simple interpretations for physicians to help them make better treatment choices. This patent-pending technology is a combination of software, Artificial intelligence, and human expertise.